Novartis Ag (NVS) Shares Outstanding (Weighted Average) (2009 - 2026)
Novartis Ag recorded quarterly Shares Outstanding (Weighted Average) of $736000.0 billion in Q1 2026, down 3.92% quarter-over-quarter from $766000.0 billion in Q4 2025, and down 3.92% year-over-year from $766000.0 billion in Q1 2025.
Novartis Ag's Shares Outstanding (Weighted Average) history runs 18 years deep, the most recent figure standing at $736000.0 billion for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) fell 3.92% year-over-year to $736000.0 billion; the TTM figure through Mar 2026 stood at $736000.0 billion (down 3.92% YoY), while the FY2025 annual figure was $766000.0 billion, up 96595108.07% from the prior year.
- Shares Outstanding (Weighted Average) came in at $736000.0 billion for Q1 2026 at Novartis Ag, down from $766000.0 billion in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $901000.0 billion in Q1 2022 to a low of $1.0 million in Q1 2023.
- A 5-year average of $372706.1 billion and a median of $2.1 billion in 2022 frame the typical range for Shares Outstanding (Weighted Average).
- Across the five-year window, Shares Outstanding (Weighted Average) slumped 100.0% in 2022 and jumped 77745097939.22% in 2024, its largest moves.
- Novartis Ag's Shares Outstanding (Weighted Average) stood at $2.1 billion in 2022, then tumbled by 61.08% to $825.0 million in 2023, then retreated by 3.88% to $793.0 million in 2024, then soared by 96595108.07% to $766000.0 billion in 2025, then dropped by 3.92% to $736000.0 billion in 2026.
- According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $736000.0 billion, $766000.0 billion, and $766000.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | 736,000.00 Bn |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 894.50 Mn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 2.41 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 1.77 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 2.47 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.24 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 5.69 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.04 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 1.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 736,000.00 Bn |
| Dec 31, 2025 | 766,000.00 Bn |
| Sep 30, 2025 | 766,000.00 Bn |
| Jun 30, 2025 | 766,000.00 Bn |
| Mar 31, 2025 | 766,000.00 Bn |
| Dec 31, 2024 | 793.00 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | 2.91 Mn |
| Mar 31, 2024 | 793,000.00 Bn |
| Dec 31, 2023 | 825.00 Mn |
| Sep 30, 2023 | 2.84 Mn |
| Jun 30, 2023 | 842,000.00 Bn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 2.12 Bn |
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 901,000.00 Bn |
| Dec 31, 2021 | 2.23 Bn |
| Sep 30, 2021 | 901,000.00 Bn |
| Jun 30, 2021 | 2,243,000.00 Bn |
| Mar 31, 2021 | 913,000.00 Bn |
| Dec 31, 2020 | 2.26 Bn |
| Sep 30, 2020 | 913,000.00 Bn |
| Jun 30, 2020 | 913,000.00 Bn |
| Mar 31, 2020 | 936,000.00 Bn |
| Dec 31, 2019 | 936.00 Mn |
| Sep 30, 2019 | 936,000.00 Bn |
| Jun 30, 2019 | 936,000.00 Bn |
| Mar 31, 2019 | 944,000.00 Bn |
| Dec 31, 2018 | 944.00 Mn |
| Sep 30, 2018 | 944,000.00 Bn |
| Jun 30, 2018 | 3.32 Mn |
| Mar 31, 2018 | 969,000.00 Bn |
| Dec 31, 2017 | 969.00 Mn |
| Sep 30, 2017 | 2.43 Mn |
| Jun 30, 2017 | 840,000.00 |
| Mar 31, 2017 | 700,000.00 |
| Dec 31, 2016 | 972.00 Mn |
| Sep 30, 2016 | 2.42 Mn |
| Jun 30, 2016 | 1.60 Mn |
| Mar 31, 2016 | 850,000.00 |
| Dec 31, 2015 | 991.00 Mn |
| Sep 30, 2015 | 2.48 Mn |
| Jun 30, 2015 | 760,000.00 |
| Mar 31, 2015 | 960,000.00 |
| Dec 31, 2014 | 4.21 Mn |
| Sep 30, 2014 | 3.37 Mn |
| Jun 30, 2014 | 2.10 Mn |
| Mar 31, 2014 | 990,000.00 |
| Dec 31, 2013 | 3.76 Mn |
| Sep 30, 2013 | 2.92 Mn |
| Jun 30, 2013 | 1.03 Mn |
| Mar 31, 2013 | 980,000.00 |
| Sep 30, 2012 | 3.09 Mn |
| Jun 30, 2012 | 2.07 Mn |
| Mar 31, 2012 | 1,250.00 Bn |
| Dec 31, 2011 | 3.83 Mn |
| Sep 30, 2011 | 3.34 Mn |
| Jun 30, 2011 | 1.13 Mn |
| Mar 31, 2011 | 1.21 Mn |
| Dec 31, 2010 | 4.28 Mn |
| Sep 30, 2010 | 3.34 Mn |
| Jun 30, 2010 | 1.06 Mn |
| Mar 31, 2010 | 1.29 Mn |
| Dec 31, 2009 | 3,700.00 Bn |
| Sep 30, 2009 | 2.69 Mn |
| Jun 30, 2009 | 1.05 Bn |
| Mar 31, 2009 | 870,000.00 |